Claudiani S, Chughtai F, Khan A, Hayden C, et al. Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 2024 Feb 29. doi: 10.1038/s41375-024-02187.
PMID: 38424138